Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 19,088 | 0 | 0 | 0 | 0 |
| Cost of Goods | 418 | N/A | N/A | N/A | N/A |
| Gross Profit | 18,670 | N/A | N/A | N/A | N/A |
| Operating Expenses | 110,226 | 58,610 | 72,429 | 105,639 | 60,443 |
| Operating Income | -91,138 | -58,610 | -72,429 | -105,639 | -60,443 |
| Other Income | 9,513 | 8,842 | 2,282 | 4,587 | -10,317 |
| Pre-tax Income | -81,625 | -49,768 | -70,147 | -101,052 | -70,760 |
| Income Tax | 502 | 1 | -179 | N/A | N/A |
| Net Income Continuous | -82,127 | -49,769 | -69,968 | -101,052 | -70,760 |
| Net Income | $-82,127 | $-49,769 | $-69,968 | $-101,052 | $-70,760 |
| EPS Basic Total Ops | -2.85 | -2.34 | -35.71 | -12.88 | -17.14 |
| EPS Basic Continuous Ops | -2.85 | -2.34 | -35.72 | -12.89 | -17.12 |
| EPS Diluted Total Ops | -2.85 | -2.34 | -35.71 | -12.88 | -17.14 |
| EPS Diluted Continuous Ops | -2.85 | -2.34 | -35.72 | -12.89 | -17.12 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.34 | N/A | -12.88 | -17.15 |
| EBITDA(a) | $-90,851 | $-58,552 | $-73,471 | $-104,887 | $-59,709 |